Email this article Pathomorphological and clinical characteristics of blastic plasmocytoid dendritic cell neoplasm. Case report
- Authors: Sherstnev A.A.1, Kovrigina A.M.1, Solovyova T.I.1, Moiseeva T.N.1
-
Affiliations:
- National Research Center for Hematology
- Issue: Vol 94, No 7 (2022)
- Pages: 891-896
- Section: Clinical notes
- URL: https://journals.rcsi.science/0040-3660/article/view/109744
- DOI: https://doi.org/10.26442/00403660.2022.07.201734
- ID: 109744
Cite item
Full Text
Abstract
The paper reveals the 5 cases date about blastic plasmacytoid dendritic cell neoplasm. The presented information demonstrates morphological, immunohistochemical data and clinical manifestations.
Full Text
##article.viewOnOriginalSite##About the authors
Andrei A. Sherstnev
National Research Center for Hematology
Author for correspondence.
Email: sherstnevandrejj@mail.ru
ORCID iD: 0000-0002-1597-4591
аспирант патологоанатомического отд-ния, врач-стажер
Russian Federation, MoscowAlla M. Kovrigina
National Research Center for Hematology
Email: sherstnevandrejj@mail.ru
ORCID iD: 0000-0002-1082-8659
д-р биол. наук, зав. патологоанатомическим отд-нием
Russian Federation, MoscowTatiana I. Solovyova
National Research Center for Hematology
Email: sherstnevandrejj@mail.ru
ORCID iD: 0000-0001-8246-6581
канд. мед. наук, врач-гематолог
Russian Federation, MoscowTatiana N. Moiseeva
National Research Center for Hematology
Email: sherstnevandrejj@mail.ru
ORCID iD: 0000-0001-9591-8508
канд. мед. наук, врач-гематолог, зав. отд-нием химиотерапии гематологических заболеваний с дневным стационаром
Russian Federation, MoscowReferences
- Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon, 2017; p. 173-8.
- Bueno C, Almeida J, Lucio P, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica. 2004;89(1):58-69.
- Wang H, Cao J, Hong X. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta Haematologica. 2012;127(2):124-7. doi: 10.1159/000334703
- Trottier AM, Cerquozzi S, Owen CJ. Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects. Blood Lymphat Cancer. 2017;7:85-93. doi: 10.2147/BLCTT.S132060
- Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994;47(4):278-82. doi: 10.1002/ajh.2830470406
- Kazakov DV, Mentze T, Burg G, et al. Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol. 2003;149:869-76. doi: 10.1046/j.1365-2133.2003.05639.x
- Dzionek A, Inagaki Y, Okawa K, et al. Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol. 2002;63(12):1133-48. doi: 10.1016/s0198-8859(02)00752-8
- Saadeh D, Kurban M, Abbas O. Plasmacytoid dendritic cell role in cutaneous malignancies. J Dermatol Sci. 2016;83(1):3-9. doi: 10.1016/j.jdermsci.2016.05.008
- Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica. 2010;95(11):1873-9. doi: 10.3324/haematol.2010.026179
- Nomburg J, Bullman S, Chung SS, et al. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2020;4(6):1006-11. doi: 10.1182/bloodadvances.2019001260
- Testa U, Pelosi E, Frankel A. CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies. Biomark Res. 2014;2(1):4. doi: 10.1186/2050-7771-2-4
- Bôle-Richard E, Fredon M, Biichlé S, et al. CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm. Leukemia. 2020;34(12):3228-41. doi: 10.1038/s41375-020-0777-1
- Torres ANB, Cats D, Mei H, et al. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm. Genes Chromosomes Cancer. 2020;59(5):295-308. doi: 10.1002/gcc.22831
- Ceribelli M, Hou ZE, Kelly PN, et al. A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm. Cancer Cell. 2016;30(5):764-78. doi: 10.1016/j.ccell.2016.10.002
- Sukswai N, Aung PP, Yin CC, et al. Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm. Am J Surg Pathol. 2019;43(10):1429-37. doi: 10.1097/PAS.0000000000001316
- Agha M, Monaghan S, Swerdlow S. Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell Neoplasm. New England J Med. 2018;379(15):1479-81. doi: 10.1056/NEJMc1808354
- Aung P, Sukswai N, Nejati R, et al. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers. 2019;11:695. doi: 10.3390/cancers11050695
Supplementary files
